Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors

Levodopa is the most commonly prescribed drug for Parkinson's disease (PD). Although levodopa improves PD symptoms in the initial stages of the disease, its long-term use is limited by development of side effects, including abnormal involuntary movements (dyskinesias) and psychiatric complicati...

Full description

Saved in:
Bibliographic Details
Main Authors: Morgese, Maria Grazia, Cassano, Tommaso, Cuomo, Vincenzo, Giuffrida, Andrea
Format: Artigo
Language:Inglês
Published: 2007
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2128772/
https://ncbi.nlm.nih.gov/pubmed/17900568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2007.07.021
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items